
IRADIMED CORPORATION
IRMDNASDAQHealthcareMedical Devices
As of Nov 13, 2026 close
- Market cap
- $1.10B
- P/E (TTM)
- 45.82
- Forward P/E
- 40.46
- Dividend yield
- 1.72%
- 52-week range
- $76.35$107.90
- Volume (live)
- -
- Avg. volume (3M)
- 120.37K
IRADIMED (IRMD) Stock Price & Financial Analysis
IRADIMED Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $84.29 - $86.17 |
|---|---|
| 52-Week High | $107.90 |
| 52-Week Low | $76.35 |
| Open | $85.19 |
| Volume (last close) | 115.21K |
| Average Volume (3M) | 120.37K |
| Revenue (TTM) | 89.34M |
|---|---|
| Net Income (TTM) | 23.98M |
| Free Cash Flow (TTM) | 25.69M |
| EPS (TTM) | $1.86 |
| Profit Margin | 26.85% |
| Operating Margin | 32.30% |
| Return on Equity (ROE) | 22.53% |
| Debt to Equity | 0.00 |
| Annual Dividend | $1.47 |
|---|---|
| Dividend Yield | 1.72% |
| Payout Ratio | 78.90% |
| Last Dividend Ex-Date | Nov 13, 2026 |
| Market Cap | 1.10B |
|---|---|
| Shares Outstanding | 12.88M |
| P/E Ratio (TTM) | 45.82 |
| Forward P/E | 40.46 |
| Price to Sales (P/S) | 12.30 |
| Price to Book (P/B) | 10.32 |
| EV/EBITDA | 32.93 |
| 50-Day MA | $85.30 |
|---|---|
| 200-Day MA | $91.74 |
| 1-Year Change | +1.19% |
Source: Market prices and company fundamentals. Data as of Nov 13, 2026. Data sources and methodology
IRADIMED at a Glance
As of the Nov 13, 2026 close, IRADIMED (IRMD) has a market capitalization of $1.10B. The stock trades at 45.8× trailing earnings, 40.5× forward earnings and 12.3× sales. Over the trailing twelve months it earned $23.98M on revenue of $89.34M (a 26.9% profit margin) and generated $25.69M of free cash flow. Revenue grew 11.0% year over year.
As of its latest reported balance sheet, it holds $63.29M in cash and securities against $0.00 of debt, a net cash position of $63.29M.
IRADIMED pays a quarterly dividend totaling $1.47 per share a year, a 1.72% yield at the Nov 13, 2026 close, with a 79% payout ratio and 1 consecutive year of dividend increases.
The share price is up 1.2% over the past year. At $85.35 (the Nov 13, 2026 close) it sits within its 52-week range of $76.35 to $107.90, below its 200-day moving average of $91.74.
ETFs Holding IRMD
Largest funds holding IRMD, by assets
As of Oct 4, 2026, IRADIMED (IRMD) is among the top 50 holdings of 2 US ETFs.
| ETF | Name | Weight | AUM | Expense Ratio |
|---|---|---|---|---|
| IHI | iShares U.S. Medical Devices ETF | 0.10% | $3.53B | 0.37% |
| AIMS | Acuitas Small Cap Active ETF | 1.11% | $84.18M | 0.75% |
Source: ETF top holdings as reported by fund issuers (largest ~50 positions per fund). Data as of Oct 4, 2026. Data sources and methodology
Frequently Asked Questions About IRADIMED
What is the current stock price for IRMD?
As of the Nov 13, 2026 close, IRMD stock trades at $85.35. The 52-week range is $76.35–$107.90, with a day range of $84.29–$86.17.
What is the P/E ratio for IRMD?
As of the Nov 13, 2026 close, IRADIMED's trailing twelve-month (TTM) P/E ratio is 45.8, meaning investors pay $45.8 for every $1 of annual earnings. The forward P/E is 40.5, reflecting analyst expectations for future earnings. IRADIMED operates in the Healthcare sector.
Does IRMD pay dividends?
Yes, IRADIMED pays a 1.72% annual dividend yield as of the Nov 13, 2026 close ($1.47 per share a year). The trailing twelve-month payout ratio is 78.9%. The most recent ex-dividend date was November 13, 2026.
What is the market cap of IRMD?
As of the Nov 13, 2026 close, IRADIMED's market capitalization is $1.10B, classifying it as a small-cap company. IRADIMED operates in the Healthcare sector within the Medical Devices industry.